Filing Details

Accession Number:
0000885590-11-000019
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-04-11 13:00:00
Reporting Period:
2011-03-04
Filing Date:
2011-04-11
Accepted Time:
2011-04-11 17:56:46
Original Submission Date:
2011-03-08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343811 Ann Norma Provencio C/O 7150 Mississauga Road
Mississauga A6 L5N 8M5
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2011-03-04 1,000 $39.87 152,432 No 4 P Direct
Common Stock, No Par Value Acquisiton 2011-03-04 195 $39.88 152,627 No 4 P Direct
Common Stock, No Par Value Acquisiton 2011-03-04 380 $39.88 153,007 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Common Stock held in the reporting person's 401k account.
  2. 102,353 of these represent restricted share units ("RSUs") held by the reporting person as compensation for her services on the Board of Directors of the issuer, including 3,423 RSUs received as dividend equivalents as a result of a dividend paid on the common stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock") on December 22, 2010.
  3. This amendment is being filed to correct the number of restricted share units/common shares that were reported in the original filing.
  4. Common Stock held in the reporting person's IRA.